Ecogene 21 Report issue

Foundation Phase 2 Phase 4
Founded: Chicoutimi Canada (2000)

Organization Overview

First Clinical Trial
2019
NCT03977792
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ecogene 21

Active Ingredients

Drugs in Phase 4 Trials (1)

evinacumab (EVKEEZA) (1 trial)

Drugs in Phase 2 Trials (2)

bor15001l7 (1 trial)

docosanol (abreva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Labialis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3